Health 2.0: future innovations and more

Health 2.0: future innovations and more, by

In November Medix Publishers was present at the Health 2.0 Europe congress in London. This succesful congress, since 2007, was visited by more than 130 speakers and 510 attendees from all over the world. In total there were 85 live demos, 100+ participants and 35 digital health investors.

The Health 2.0 Conference is the leading showcase of ‘cutting-edge’ innovation that's transforming health and health care. At the congress the best minds, technologies and resources were presented in compelling panels, discussions, and live product demonstrations. During the 3-day congress 85 live demo’s about the newest innovations in health 2.0 were held. The congress had a wide theme, from patient 2.0, apps for child behavioral disorders, hospital tools for HCPs and special investment workshops at the last day. Medix Publishers highlights the most impressive presentations. Also, we created our own top 10 innovations that stood out in London at Health 2.0.

Our top 10 best innovations that stood out at Health 2.0, in a random order:

  1. Tinnitracks – Headphones that filter your own music files to change them to cure tinnitus
  2. Sensoria – Smart socks which collect data and can be washed
  3. MySugr – Tame the diabetes ‘monster’ with the app in a gamification way
  4. Dr. Omnibus – New tool for supporting the therapy of children by gamification
  5. Zombierun by sixtostart - Running app, escape zombies to increase your Health
  6. Mint labs – For neurologists, shows brains in 3d with fibers and colors 
  7. U motif - Registrate your daily health, just by sliding the ‘flower leaves’
  8. Zero mothers die – App to save the lives of pregnant women and their newborns 
  9. 2ndAid – Created by kids, an app that assist unfortunate kids who suffer from diseases
  10. Harimata – A new way of kids therapy: play, scan and detect tool

The opening of Health 2.0 started with the co-chairman Matthew Holt and the international Director Pascal Lardier. They invited Kemal Malik, Head of innovation Bayer on stage. He presented the drug development process and how innovations can be part of creating new medicine, and saving lives. "Men’s life expectancy doubled in the past 150 years: in 1863 the average life expectancy was 40, now it’s 80."

The most popular topics were telehealth, patient-provider communication and open-(medical)data. The demos Dr.Doctor and Medopad showed a lot of potential in patient communication, from HCP to patient. Also (with the app you can find own experts who will take a look at your data) and Babylon showed different views of interaction between the patient and the HCP. It all leads back to the question: Open data or not?

Investors want open data
Tim Kelsey, national director for patients and information of NHS England is not against it at all, but has no yes-or-no-answer. "Big data is about much more precision and getting the basis right.” The attendees interacted as well. Michael Dillhyon CEO of Healthbank: “It’s like we are all in the building and a big fire breaks out. Only we put 3 locks on the doors.” The refutation from the audience: “It’s our private data, we should own it, not some big company. Who will protect it?” After this discussion iHealth labs Europe president Uwe Diegel jumped in as well during his presentation. "All we really need is a good service for our data, not more products." Eventually he did show a white box called ‘Ihealth discovery’ that should be the medical data keeper in your own house.

Investor's place
At day three the EC to VC Track Session was held. The difference between the EU and USA: in the US healthcare is a single market. There’s a market for startups that deliver a better value of care in the EU. A specific field, for instance, is a cardiology innovation. It has system wide application in the EU. On the other hand an IT-system is constraint to the specific context of the local health system and thus less applicable for funding in the EU by VC capital. In the US the VC community has been around a lot longer. The EU is behind due to less access to systems for VC capital. It’s far more integrated to fund seed stage health innovation in the US than it is in the EU.

Thanks to the committee of Health 2.0 and special thanks to Hans Dijkstra from Health 2.0 Amsterdam. This Wednesday, at 6 P.M. there will be a meeting for Health 2.0 Amsterdam. Interested?  Take a look at meetup and join the sessions.

Commenting, powered by Disqus

« Back to the overview

Follow us